phrykt

Ardelyx, Inc. (ARDX): who owns it and who trades it

As of Nov 16, 2026, ARDX insiders reported 74 open-market sales worth $4.3M and 1 purchase worth $1.9M in the last 12 months, with 48% of the sale value made under pre-set 10b5-1 plans. The largest seller was Michael Raab (CEO), with $2.6M. 3 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Ardelyx

From the latest filings

Overall: more selling than buying. Insiders and famous investors mostly sold. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns ARDX

248 funds and institutions reported ARDX shares worth $916M at the end of Q2 2026, about 73% of the company. The largest holder is BlackRock, Inc. with 9.5%.

Funds and institutions (13F) 73%Everyone else 27%

10 largest owners, by share of the company

BlackRock, Inc.9.5%
Rubric Capital Management LP6.6%
Millennium Management LLC5.6%
State Street Corp5.4%
Vanguard Capital Management LLC4.2%
Nomura Asset Management International Inc.3.9%
Vanguard Portfolio Management LLC3.2%
Geode Capital Management, LLC2.6%
Jupiter Topco LLC2.1%
Two Sigma Investments, LP2.1%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.23.50M9.51%$120M+11%
Rubric Capital Management LP16.20M6.56%$82.6M+771%
Millennium Management LLC13.90M5.63%$70.9M-22%
State Street Corp13.36M5.41%$68.1M-2%
Vanguard Capital Management LLC10.47M4.24%$53.4M+1%
Nomura Asset Management International Inc.9.55M3.86%$48.7M+17%
Vanguard Portfolio Management LLC8.03M3.25%$40.9M+20%
Geode Capital Management, LLC6.40M2.59%$32.7M+7%
Jupiter Topco LLC5.30M2.15%$27M–
Two Sigma Investments, LP5.21M2.11%$26.6M+22%
Nuveen, LLC4.00M1.62%$20.4M-24%
Goldman Sachs Group Inc3.69M1.49%$18.8M+15%
AIGH Capital Management LLC3.20M1.30%$16.3M–
Morgan Stanley2.39M0.97%$12.2M+40%
AQR Capital Management LLC2.32M0.94%$11.8M-5%
Northern Trust Corp2.28M0.92%$11.6M+10%
Rock Springs Capital Management LP2.24M0.91%$11.4M-3%
Charles Schwab Investment Management Inc2.21M0.90%$11.3M+5%
Sixth Street Partners Management Company, L.P.2.21M0.90%$11.3M–
Bank of America Corp2.16M0.88%$11M-7%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, ARDX insiders reported $1.9M of open-market purchases and $4.3M of sales. 48% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$1.9M
1 trades, 1 people
Sales, 12 months
$4.3M
74 trades, 9 people
Sales under a 10b5-1 plan
48%
Share of sale value
Latest trade
Aug 21, 2026
Filed Aug 25, 2026

Purchases and sales by month

$1.9M$1.9MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 21, 2026Susan HohenleitnerCFOSale1,558$3.86$6KForm 4
Aug 21, 2026Joseph James ReillySee RemarksSale1,110$3.86$4.3KForm 4
Aug 21, 2026Joseph James ReillySee RemarksSale2,872$3.86$11.1KForm 4
Aug 21, 2026John E BishopSee RemarksSale17,281$3.86$66.7KForm 4
Aug 21, 2026John E BishopSee RemarksSale2,469$3.86$9.5KForm 4
Aug 21, 2026James Parker BradyChief Human Resources OfSale13,160$3.86$50.8KForm 4
Aug 21, 2026James Parker BradyChief Human Resources OfSale1,976$3.86$7.6KForm 4
Aug 21, 2026Eric Duane FosterChief Commercial OfficerSale2,598$3.86$10KForm 4
Aug 21, 2026Eric Duane FosterChief Commercial OfficerSale3,389$3.86$13.1KForm 4
Aug 21, 2026Eric Duane FosterChief Commercial OfficerSale2,575$3.86$9.9KForm 4
Aug 21, 2026Mike KelliherChief Business OfficerSale3,104$3.86$12KForm 4
Aug 21, 2026Mike KelliherChief Business OfficerSale2,002$3.86$7.7KForm 4
Aug 21, 2026Mike KelliherChief Business OfficerSale2,652$3.86$10.2KForm 4
Aug 21, 2026Laura A WilliamsChief Patient OfficerSale3,486$3.86$13.5KForm 4
Aug 21, 2026Laura A WilliamsChief Patient OfficerSale1,734$3.86$6.7KForm 4
Aug 21, 2026Laura A WilliamsChief Patient OfficerSale2,430$3.86$9.4KForm 4
Aug 21, 2026Laura A WilliamsChief Patient OfficerSale3,089$3.86$11.9KForm 4
Aug 21, 2026Michael RaabCEOSale15,009$3.86$57.9KForm 4
Aug 21, 2026Michael RaabCEOSale19,178$3.86$74KForm 4
Aug 21, 2026Michael RaabCEOSale15,976$3.86$61.7KForm 4
Aug 21, 2026Michael RaabCEOSale8,411$3.86$32.5KForm 4
Jul 15, 2026Michael RaabCEOSale plan41,668$5.06$211KForm 4
Jun 18, 2026Laura A WilliamsChief Patient OfficerSale plan81,898$5.99$491KForm 4
Jun 15, 2026Michael RaabCEOSale plan41,666$5.67$236KForm 4
May 21, 2026Joseph James ReillySee RemarksSale2,683$6.27$16.8KForm 4
May 21, 2026Joseph James ReillySee RemarksSale1,036$6.27$6.5KForm 4
May 21, 2026Susan HohenleitnerCFOSale1,455$6.27$9.1KForm 4
May 21, 2026John E BishopSee RemarksSale2,306$6.27$14.5KForm 4
May 21, 2026James Parker BradyChief Human Resources OfSale1,846$6.27$11.6KForm 4
May 21, 2026Eric Duane FosterChief Commercial OfficerSale2,427$6.27$15.2KForm 4
May 21, 2026Eric Duane FosterChief Commercial OfficerSale3,166$6.27$19.9KForm 4
May 21, 2026Eric Duane FosterChief Commercial OfficerSale2,405$6.27$15.1KForm 4
May 21, 2026Mike KelliherChief Business OfficerSale2,900$6.27$18.2KForm 4
May 21, 2026Mike KelliherChief Business OfficerSale1,870$6.27$11.7KForm 4
May 21, 2026Mike KelliherChief Business OfficerSale2,478$6.27$15.5KForm 4
May 21, 2026Laura A WilliamsChief Patient OfficerSale1,418$6.27$8.9KForm 4
May 21, 2026Laura A WilliamsChief Patient OfficerSale1,911$6.27$12KForm 4
May 21, 2026Laura A WilliamsChief Patient OfficerSale1,503$6.27$9.4KForm 4
May 21, 2026Laura A WilliamsChief Patient OfficerSale2,157$6.27$13.5KForm 4
May 21, 2026Michael RaabCEOSale14,028$6.27$88KForm 4
May 21, 2026Michael RaabCEOSale17,926$6.27$112KForm 4
May 21, 2026Michael RaabCEOSale7,861$6.27$49.3KForm 4
May 21, 2026Michael RaabCEOSale14,933$6.27$93.6KForm 4
May 15, 2026Michael RaabCEOSale plan41,666$6.28$262KForm 4
Apr 15, 2026Michael RaabCEOSale plan41,668$6.29$262KForm 4
Mar 16, 2026Michael RaabCEOSale plan41,666$5.84$243KForm 4
Feb 24, 2026Michael RaabCEOSale41,666$6.26$261KForm 4
Feb 20, 2026David M MottDirectorPurchase333,333$5.84$1.9MForm 4
Feb 20, 2026John E BishopSee RemarksSale2,792$5.87$16.4KForm 4
Feb 20, 2026John E BishopSee RemarksSale1$5.70$6Form 4
Feb 20, 2026John E BishopSee RemarksSale386$5.71$2.2KForm 4
Feb 20, 2026Joseph James ReillySee RemarksSale602$5.71$3.4KForm 4
Feb 20, 2026Joseph James ReillySee RemarksSale4,387$5.87$25.8KForm 4
Feb 20, 2026Joseph James ReillySee RemarksSale2$5.70$11Form 4
Feb 20, 2026Laura A WilliamsSee RemarksSale984$5.71$5.6KForm 4
Feb 20, 2026Laura A WilliamsSee RemarksSale7,192$5.87$42.2KForm 4
Feb 20, 2026Susan HohenleitnerCFOSale1,786$5.87$10.5KForm 4
Feb 20, 2026Susan HohenleitnerCFOSale247$5.71$1.4KForm 4
Feb 20, 2026James Parker BradyChief Human Resources OfSale2,234$5.87$13.1KForm 4
Feb 20, 2026James Parker BradyChief Human Resources OfSale309$5.71$1.8KForm 4
Feb 20, 2026Mike KelliherSee RemarksSale8,434$5.87$49.5KForm 4
Feb 20, 2026Mike KelliherSee RemarksSale1,159$5.71$6.6KForm 4
Feb 20, 2026Mike KelliherSee RemarksSale2$5.71$11Form 4
Feb 20, 2026Michael RaabCEOSale40,401$5.87$237KForm 4
Feb 20, 2026Michael RaabCEOSale5,576$5.71$31.8KForm 4
Feb 20, 2026Eric Duane FosterChief Commercial OfficerSale1,261$5.71$7.2KForm 4
Feb 20, 2026Eric Duane FosterChief Commercial OfficerSale1$5.71$6Form 4
Feb 20, 2026Eric Duane FosterChief Commercial OfficerSale9,176$5.87$53.9KForm 4
Jan 8, 2026Laura A WilliamsChief Patient OfficerSale plan50,000$6.98$349KForm 4
Nov 21, 2025Elizabeth A GrammerSee RemarksSale5,995$5.54$33.2KForm 4
Nov 21, 2025Michael RaabCEOSale46,887$5.54$260KForm 4
Nov 21, 2025Mike KelliherSee RemarksSale5,560$5.54$30.8KForm 4
Nov 21, 2025Laura A WilliamsChief Patient OfficerSale6,426$5.54$35.6KForm 4
Nov 21, 2025Eric Duane FosterChief Commercial OfficerSale5,814$5.54$32.2KForm 4
Nov 21, 2025Joseph James ReillySee RemarksSale11,086$5.54$61.4KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Michael RaabPresident & CEO, Director–$2.6MAug 21, 2026
David M MottDirector$1.9M–Feb 20, 2026
Laura A WilliamsChief Patient Officer–$1MAug 21, 2026
Eric Duane FosterChief Commercial Officer–$176KAug 21, 2026
Mike KelliherSee Remarks–$162KAug 21, 2026
Joseph James ReillySee Remarks–$129KAug 21, 2026
John E BishopSee Remarks–$109KAug 21, 2026
James Parker BradyChief Human Resources Officer–$84.9KAug 21, 2026
Elizabeth A GrammerSee Remarks–$33.2KNov 21, 2025
Susan HohenleitnerChief Financial Officer–$27KAug 21, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

ARDX short interest

High short interest. 11.6% of ARDX shares are sold short: about 1 share in 9. Over the last 12 reports the number of shares short went up 22%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 29.21M ARDX shares were sold short, 11.6% of the shares outstanding, down 3.4% from the report before. At the average daily volume of 3.88M shares, buying them all back would take about 7.5 trading days (days to cover).

Shares short, % of all shares

11.6%May 15Oct 3012.6%

Days to cover

7.5May 15Oct 3012.2

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202629.21M11.62%-3%3.88M7.5
Oct 15, 202630.24M12.13%+9%4.67M6.5
Sep 30, 202627.68M11.11%+8%4.19M6.6
Sep 15, 202625.60M10.27%+13%4.04M6.3
Aug 31, 202622.72M9.12%+1%3.70M6.1
Aug 14, 202622.43M9.00%-15%6.77M3.3
Jul 31, 202626.24M10.53%No change2.38M11.0
Jul 15, 202626.25M10.63%+3%3.26M8.1
Jun 30, 202625.37M10.27%-6%6.28M4.0
Jun 15, 202626.94M10.91%+9%3.14M8.6
May 29, 202624.78M10.03%+4%2.56M9.7
May 15, 202623.86M9.66%+1%5.25M4.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Ardelyx company events

Ardelyx filed 9 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 3, 2026.

  1. Nov 3, 2026ResultsReleased financial results. Filing
  2. Aug 17, 2026AnnouncementEric Foster notified Ardelyx, Inc. of his decision to resign as Chief Commercial Officer of the Company, effective August 28, 2026. Filing
  3. Aug 6, 2026ResultsReleased financial results. Filing
  4. Jul 2, 2026DebtTook on new debt. Filing
  5. Jun 17, 2026LeadershipThe Board of Directors of Ardelyx, Inc. approved the second amendment to the Company’s Amended and Restated 2014 Equity Incentive Award Plan. Filing
  6. Apr 30, 2026ResultsReleased financial results. Filing
  7. Feb 19, 2026ResultsReleased financial results. Filing
  8. Jan 8, 2026AnnouncementThe information set forth in Item 2.02 is incorporated into this Item 8.01 by reference. Filing
  9. Dec 17, 2025LeadershipElizabeth Grammer informed Ardelyx, Inc. of her resignation as the Company’s Chief Legal and Administrative Officer, effective December 31, 2025. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Ardelyx financials

Famous investors that hold ARDX

3 of the 50 well-known investors we track reported holding ARDX in their latest 13F filing. The largest position is Israel Englander's, worth $46M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 202613.46M$46M0.0%-3%
Ken Griffin · Citadel AdvisorsQ3 20261.39M$4.7M0.0%+35%
Jim Simons · Renaissance TechnologiesQ3 2026119,067$407K0.0%-87%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Ardelyx, Inc. (ARDX) stock

Who owns the most ARDX stock?

The largest reported owner of Ardelyx, Inc. (ARDX) is BlackRock, Inc., with 9.5% of the company. In total, 248 funds and institutions reported holding ARDX at the end of Q2 2026, together about 73% of the shares. See the largest owners.

Are ARDX insiders buying or selling?

In the last 12 months, ARDX insiders reported 1 open-market purchase worth $1.9M and 74 sales worth $4.3M. The latest trade was on Aug 21, 2026. See every trade.

What is the short interest in ARDX?

As of Oct 30, 2026, 29.21M ARDX shares were sold short, 11.6% of the shares outstanding, down 3.4% from the report before. At the average daily volume of 3.88M shares, buying them all back would take about 7.5 trading days (days to cover). See the history.

Which famous investors hold ARDX?

3 of the 50 well-known investors we track reported ARDX in their latest 13F filing, including Israel Englander, Ken Griffin, Jim Simons. The largest position is worth $46M. See all holders.

Executive pay

Ardelyx's chief executive was paid a total of $7.8M for the year ended Dec 31, 2025, down 19% from $9.6M the year before. In the last 12 months, Ardelyx's executives and directors bought $1.9M of stock on the open market and sold $4.3M.

Chief executive, total pay$7.8MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$8.3MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$3.1MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.